Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 5Phase 3 3Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Vitamin D Deficiency 1Stroke 1Spinal Cord Injuries 1Seizures 1Polyps 1Neoplasms 1Musculoskeletal Diseases 1Meningitis 1Intracranial Hemorrhages 1Intracranial Aneurysm 1Critical Illness 1Craniocerebral Trauma 1Colorectal Neoplasms 1Brain Neoplasms 1Adenomatous Polyps 1Adenoma 1

Interventions

Capecitabine 16Paclitaxel 12Docetaxel 10Cyclophosphamide 10Epirubicin 8Gemcitabine 7Letrozole 6Doxorubicin 6Carboplatin 6Trastuzumab 5Vinorelbine 4Cisplatin 4pertuzumab 3exemestane 3Neoadjuvant Therapy 3Drug Therapy 3Ado-Trastuzumab Emtansine 3AC protocol 3130-nm albumin-bound paclitaxel 3apatinib 2Zoledronic Acid 2Thiotepa 2Taxes 2Tamoxifen 2Standard of Care 2Radiosurgery 2Melatonin 2Lapatinib 2Injections 2Goserelin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Breast Neoplasms × Cholecalciferol × Clear all
NCT05523609 2023-12-01

Vitamin D and Calcium Supplementation in Breast Cancer

Tanta University

Phase 2/3 Unknown
40 enrolled
Breast

Breast Neoplasms

NCT01809171 2015-10-21

Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients

Universitaire Ziekenhuizen KU Leuven

Phase 2/3 Terminated
15 enrolled
Breast

Breast Neoplasms, Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡